510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K241921Substantially Equivalent

Alinity m BKV

Abbott Molecular, Inc., Des Plaines IL / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K241921 is the FDA 510(k) clearance record for Alinity m BKV, a class II device, cleared for Abbott Molecular, Inc. on under FDA product code QMI (Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna). FDA's definition for product code QMI reads: "An in vitro nucleic acid amplification test for the quantitation of BK virus (BKV) DNA in human samples intended for use as an aid in the management of BKV in transplant patients. In patients undergoing monitoring of BKV, serial DNA...". FDA records list 19 510(k) clearances for Abbott Molecular, Inc., from to . As of , FDA records show no recalls naming K241921.

Clearance record

Decision date
Received
(266 days to decision)
Product code
QMI Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna
Regulation
21 CFR 866.3183
Device class
Class II
Review panel
Microbiology
Applicant
Abbott Molecular, Inc. 1300 E Touhy Ave., Des Plaines IL
510(k) summary
Summary PDF
Third party review
No

Clearances, product code QMI

Trailing 12 months

FDA records hold no clearances under product code QMI in the trailing twelve months.

FDA records show no clearances under product code QMI in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code QMI, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260